✦ LIBER ✦

EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma

✍ Scribed by De Mulder, PHM; Oosterhof, G; Bouffioux, C; van Oosterom, AT; Vermeylen, K; Sylvester, R

Book ID: 109837207
Publisher: Nature Publishing Group
Year: 1995
Tongue: English
Weight: 982 KB
Volume: 71
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1995.75

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-alpha antibodies in patients

Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial

✍ Otto Prümmer; Delta-P Study Group 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 657 KB

Background. Prolonged therapy with interferon (IFN) may lead to the formation of IFN antibodies. Methods. Patients with renal cell carcinoma (n = 270) with advanced localized disease were randomized after complete tumor resection to receive treatment with adjuvant recombinant IFN-alpha-2a (rIFN-a2a

Recombinant Interferon-alpha with or wit

Recombinant Interferon-alpha with or without Vinblastine in Metastatic Renal Carcinoma Results of a Randomised Phase II Study

✍ SOPHIE D. FOSSÅ; N. RAABE; BRIT MOE 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

Subcutaneous low-dose recombinant interl

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma

✍ Gaston, R; Oskam, R; Philip, T; Ravaud, A; Négrier, S; Cany, L; Merrouche, Y; Le 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 876 KB

Intensive recombinant interleukin-2 and

Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma

✍ Susan G. Urba; Arlene A. Forastiere; Gregory T. Wolf; Philip C. Amrein 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Role of recombinant interferon alpha2and

Role of recombinant interferon alpha2and cimetidine in patients with advanced malignant melanoma

✍ Tariq I. Mughal; William A. Robinson; M. Roy Thomas; Robert Spiegel 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 190 KB

Phase II study of recombinant beta inter

Phase II study of recombinant beta interferon in patients with advanced non-small-cell lung carcinoma

✍ Ettinger, David S. ;Harwood, Kerry 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Eighteen patients with advanced non-smallcell lung cancer (NSCLC) received recombinant beta interferon, 90 million units three times weekly. No complete or partial responses were seen. Five patients had stable disease for several months. Most patients experienced some toxicity, most commonly fever a